Biosino Bio-Technology and Science Incorporation (HKG:8247)

HKG:8247 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	619	110	116	184	246	243
Market Cap Growth	470.67%	-5.00%	-37.01%	-25.29%	1.19%	-13.40%
Enterprise Value	729	250	252	316	443	425
Last Close Price	4.28	0.76	0.80	1.27	1.70	1.68
PE Ratio	-	-	-	20.06	-	75.32
PS Ratio	2.51	0.39	0.36	0.44	0.58	0.63
PB Ratio	3.64	0.59	0.45	0.69	1.00	1.04
P/TBV Ratio	4.34	0.69	0.55	0.89	1.30	1.28
P/FCF Ratio	57.80	9.10	-	5.77	4.44	-
P/OCF Ratio	18.73	4.35	-	3.65	4.10	18.00
EV/Sales Ratio	2.96	0.89	0.79	0.75	1.04	1.10
EV/EBITDA Ratio	-	-	-	6.84	7.23	37.88
EV/EBIT Ratio	-	-	-	14.18	14.23	-
EV/FCF Ratio	68.06	20.65	-	9.93	8.00	-
Debt / Equity Ratio	0.91	0.88	0.65	0.65	0.87	1.05
Debt / EBITDA Ratio	-	-	231.22	3.47	3.27	15.63
Debt / FCF Ratio	14.47	13.54	-	5.38	3.84	-
Asset Turnover	0.46	0.51	0.50	0.62	0.56	0.51
Inventory Turnover	2.42	2.71	2.79	3.93	3.26	3.51
Quick Ratio	0.56	0.67	0.79	0.87	0.66	0.69
Current Ratio	0.90	0.97	1.09	1.15	1.05	1.02
Return on Equity (ROE)	-33.40%	-28.03%	-8.27%	6.55%	1.60%	-0.36%
Return on Assets (ROA)	-5.62%	-4.48%	-2.08%	2.04%	2.57%	-1.16%
Return on Invested Capital (ROIC)	-17.45%	-13.22%	-6.34%	4.86%	3.74%	1.17%
Return on Capital Employed (ROCE)	-26.90%	-20.20%	-8.00%	7.70%	11.60%	-4.80%
Earnings Yield	-8.37%	-41.16%	-11.09%	4.99%	-0.57%	1.33%
FCF Yield	1.73%	10.99%	-21.80%	17.34%	22.53%	-1.17%
Payout Ratio	-	-	-	-	-	41.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.